West-ward Pharmaceuticals
Executive Summary
Moore Medical agrees June 19 to sell its generic drug subsidiary to the Hikma Investment Co. for an undisclosed amount. Moore's 1990 financial statements treated West-ward as a discontinued operation and provided for the estimated loss on disposition. Hikma, a manufacturer of pharmaceuticals and chemicals, has operations in Europe and the Middle East. Moore purchased the business in 1988 and immediately had concerns about previous discrepancies in recordkeeping ("The Pink Sheet" Dec. 24, p. 10)